Alexander Brian Lippold is an innovative inventor based in Webster Groves, Missouri. With a focus on pharmaceutical advancements, Lippold has contributed to the field through his patented work in delayed sustained release compositions, thereby enhancing therapeutic efficacy over extended periods.

Latest Patents

Lippold holds a notable patent titled "Delayed Sustained Release Pharmaceutical Compositions." This patent specifically addresses the development of pharmaceutical compositions that can provide therapeutic effects lasting 14 to 16 hours. This innovation aims to improve patient adherence and treatment outcomes by minimizing the frequency of dosing.

Career Highlights

Currently, Alexander is associated with Specgx LLC, a company that emphasizes research in the pharmaceutical domain. His work contributes uniquely to the company's mission of delivering effective and innovative medical solutions. Lippold's expertise in formulating extended-release compositions reflects his dedication to pushing the boundaries of pharmaceutical science.

Collaborations

Throughout his career, Lippold has collaborated with talented professionals such as Tsz Chung Lai and Rebecca Sue Walker. These collaborations signify the importance of teamwork in driving innovation and achieving successful solutions in pharmaceutical research and development.

Conclusion

Alexander Brian Lippold’s contributions to the field of pharmaceuticals highlight the essential role of inventors in improving healthcare. His work demonstrates how innovative thinking can lead to significant advancements, ultimately benefiting patients and healthcare providers alike. Through his patent and collaborative efforts at Specgx LLC, Lippold continues to pave the way for future innovations in the industry.

Profile summary based on public USPTO records.